December 29, 2017 / 6:14 PM / 6 months ago

Pershing Square and Valeant reach agreement on settlement split

Dec 29 (Reuters) - Activist investor William Ackman’s Pershing Square said on Friday it had reached an agreement with Valeant Pharmaceuticals to split settlement costs of a lawsuit related to Allergan Plc.

Pershing Square said Valeant will now pay around 33 percent, or $96.25 million, of the settlement costs. Valeant had previously agreed to pay 60 percent of the costs. (Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below